13 participants
Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-08-22
- Start Date:
- 2008-03-31
- Completion:
- 2010-03-31
Conditions
- Myelofibrosis
Interventions
- DRUG